New approaches to immunotoxicity testing.
نویسنده
چکیده
New approaches to immunotoxicity testing are reviewed and discussed. A method of activating T-cells in vivo is presented which circumvents artifacts dur to viability effects encountered with in vitro mitogen assays. The use of adoptive transfer approaches to combine the advantages of in vitro manipulation with in vivo function assays is discussed relative to natural killer cells. The need for an in vitro metabolic activation step coupled to other in vitro immunologic assays is discussed.
منابع مشابه
Immunotoxicology: challenges in the 21st century and in vitro opportunities.
Over the last two decades, little has changed in the practice of immunotoxicity testing for regulatory purposes, especially for immunosuppression, and autoimmunity is still a challenge. Current guidelines still rely on animal tests, which include some immune endpoints in repeated dose tests and trigger dedicated tests only when certain alerts indicate a problem. At the same time, however, a wea...
متن کاملComparison of two guidelines on immunotoxicity testing of medicinal products.
Despite the lack of formal immunotoxicity testing guidelines, the assessment of immune function has been a routine component of toxicity testing for over twenty years. The European Agency for the Evaluation of Medicinal Products (EMEA) and The US Food and Drug Administration (FDA) have recently adopted new guidelines for immunotoxicity testing of new medicinal products. These two guidelines are...
متن کاملEvaluation and prevalidation of an immunotoxicity test based on human whole-blood cytokine release.
Immunotoxicology is a relatively new field in toxicology, and is one of emerging importance, because immunotoxicity appears to contribute to the development of cancer, autoimmune disorders, allergies and other diseases. At present, there is a lack of human cell-based immunotoxicity assays for predicting the toxicity of xenobiotics toward the immune system in a simple, fast, economical and relia...
متن کاملImmunotoxicity, Immunogenicity and Immunopharmacology of Therapeutic Proteins, by J. L. Bussiere; P1208.1104
Introduction Immunotoxicity testing for biotechnology products such as human proteins and monoclonal antibodies is often conducted in nonhuman primates. These human proteins may not be pharmacologically active in rodents or may be immunogenic, such that rodents would develop neutralizing antibodies to the drug. These don’t appear to be very significant points!!! There are certain advantages to ...
متن کاملA comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements
Nanomaterials (NMs) are attractive for biomedical and pharmaceutical applications because of their unique physicochemical and biological properties. A major application area of NMs is drug delivery. Many nanomedicinal products (NMPs) currently on the market or in clinical trials are most often based on liposomal products or polymer conjugates. NMPs can be designed to target specific tissues, eg...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Environmental Health Perspectives
دوره 43 شماره
صفحات -
تاریخ انتشار 1982